HCAP Partners Invests in Real Diagnostics for Growth Expansion
HCAP Partners has announced its investment in Real Diagnostics, a clinical laboratory specializing in rapid and accurate testing, announced in a press release. This investment supports Salt Creek Capital's acquisition of RealDx and aims to expand access to high-quality diagnostic services.
RealDx provides diagnostic services across 17 states, offering test results within 24 hours and leveraging proprietary technology to enhance diagnostic accuracy. The company serves physician offices, specialty clinics, and skilled nursing facilities, distinguishing itself with its rapid and precise testing capabilities.
Cary Breese, the incoming CEO of RealDx, brings over 20 years of experience in healthcare and technology, having previously co-founded NowRx. With the support of Salt Creek Capital and HCAP Partners, RealDx is poised to expand its reach and continue delivering timely, accurate diagnostics to improve patient care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Sopris Capital Acquires Blackford Analysis from Bayer
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
HOPPR Brings Radiology Foundation Models to CARPL.ai
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Healthcare Triangle Joins Kanzun-ARCB Fund to Connect Malaysian Companies With US Capital
Daily AI Brief: the AI news that matters, in your inbox.